You are here

Coronavirus Outbreak

Coronavirus Top News

Press Release | May 28, 2020
WASHINGTON, D.C. – Recent nationwide polling data shows 75% of Americans are ready to visit the doctor’s office again. Guidance released last week by AdvaMed, AORN, AHA “an important step” to resuming critical medical procedures.”
Press Release | May 19, 2020
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed), the Association of periOperative Registered Nurses (AORN), and the American Hospital Association (AHA) today released “Re-entry Guidance for Health Care Facilities and Medical Device Representatives.” As health care professionals and organizations consider when and how to safely resume elective surgeries paused during the COVID-19 pandemic, this guidance adds principles and considerations to support the vital collaboration between health care personnel and medical device representatives.
Blog Post | May 11, 2020
Behind the scenes, the medical technology industry is working around-the-clock to manufacture the critical supplies providers need to combat the coronavirus. Across the country, manufacturers are adding shifts, ramping up alternative production lines and working overtime to produce personal protective equipment (PPE), ventilators and the diagnostic tests desperately needed on the front lines.

More news

AdvaMed Members Fight Coronavirus

Since the onset of the coronavirus (COVID-19) outbreak, AdvaMed member companies have donated millions of dollars’ worth of medical products and cash to hospitals, foundations and charities around the world. Medical device companies are responding to increased demand by ramping up production wherever possible, coordinating closely with governments to ensure the delivery of supplies where they are most needed, and in some cases, creating new devices and diagnostic tests to help effectively diagnose and treat sick patients.

We have assembled a collection of some of the efforts undertaken by AdvaMed member companies based on public statements.

Read more

In Vitro Diagnostic COVID-19 Tests

In vitro diagnostic (IVD) manufacturers have taken key steps to increase patient access to coronavirus diagnostic testing in laboratories, hospitals, and other testing sites across the country to guide patient care and protect public health.

We have compiled a list of companies that have developed IVDs that have received Emergency Use Authorization from the U.S. Food and Drug Administration.

View the list

Diagnostics Resources

MedTech’s Role in Combatting COVID-19

The medical technology industry recognizes its crucial role in our nation’s health care system, particularly during an unprecedented public health emergency such as the COVID-19 pandemic. This crisis has united us all as Americans in a global fight. The patients our industry serves have always been our No. 1 priority, and we are working around the clock to meet their needs. We are committed as medical technology innovators and manufacturers to working with federal, state, and local authorities to ensure our nation’s disaster planning efforts are coordinated, efficient, and effective. For weeks now, the medtech industry has been mobilizing to this global cause, and we are committed to the following guiding principles in our efforts to conquer the coronavirus.

Read more

Coronavirus Task Force

AdvaMed is actively working with key U.S. government agencies – including HHS, FDA, and CDC – as well government agencies around the world, to identify how the industry can help ensure that providers and patients everywhere have access to the medical technologies they need to help diagnose and fight this deadly virus.

As we continue to assess and respond to a crisis that continues to evolve, AdvaMed’s objective is to pool and disseminate industry knowledge, and share developments among our membership.

To that end, AdvaMed has assembled a coronavirus task force. Any AdvaMed member company is eligible to join. This task force meets during scheduled conference calls and provides readouts on the latest intel we are receiving from AdvaMed members, government agencies and other stakeholders.

Join the Task Force